Enzyme replacement therapy for treating lysosomal storage diseases
US10265412B2 · kind B2 · utility
0Cited by
4References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 6, 2007 |
| Grant date | Apr 23, 2019 |
| Priority date | — |
| Expiry date | May 9, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates in general to the field of enzyme replacement therapy, and specifically to chimeric proteins including protein hormone-therapeutic protein conjugates and fusion proteins, wherein the protein hormone is selected from a protein hormone which is able to cross the blood brain barrier, for the treatment of lysosomal storage diseases, compositions of the same and to methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.